Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
On Feb. 26, 2020, the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories (NIAID-RML) announced it…
On Feb. 26, 2020, Tonix Pharmaceuticals announced a strategic collaboration with Southern Research to support the development of…
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
On Feb. 12, 2020, leading health experts from around the world met at the World Health Organization’s (WHO)…
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
On Feb. 10, 2020, the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced…
On Feb. 5, 2020, to fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally,…
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…
On Jan. 30, 2020, the Centers for Disease Control and Prevention (CDC) confirmed that the 2019 Novel Coronavirus…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
On Jan. 28, 2020, the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, met President…
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
On Jan. 26, 2020, the Bill & Melinda Gates Foundation announced that it had immediately committed $10 million…
On Jan. 22, 2020, Johns Hopkins engineering professor Dr. Lauren Gardner created the COVID dashboard used around the…
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
On Jan. 9, 2020, the World Health Organization announced that a novel coronavirus had been identified as the…
On Dec. 31, 2019, the World Health Organization (WHO) declared the Coronavirus outbreak a global pandemic. To date,…
On Apr. 13, 2003, the International Human Genome Sequencing Consortium announced the completion of the Human Genome Project…